Beside the implication of HIF1α and HIF2α in LSCs maintenance, leukemia proliferation and survival that was previously described, other studies have revealed that HIF1α and HIF2α may display tumor-suppressive roles or no relevant functions in AML development and progression. The gene discussed is EPAS1; the disease is acute myeloid leukemia.